Vesugen – Short Vascular Peptide
Vesugen is an ultra-short tri-peptide (Lys-Glu-Asp) that targets vascular endothelial tissue with exceptional bioavailability. Its minimal size allows rapid cellular uptake, making it one of the most efficient Bosom Peptides for microvascular tone and endothelial barrier support.
Description
Vesugen is a precision-engineered bioregulator peptide that selectively targets blood vessels through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within blood vessels cells, Vesugen helps normalise microvascular tone and endothelial barrier function—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for cardiovascular tissue maintenance, making it a fundamentally different approach from conventional supplementation.